Schedule 13G ownership disclosure

CELLECTAR BIOSCIENCES INC

Security class unavailable · CUSIP: 15117F500

Event date: 2022-10-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
605,228
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001622627-22-000006
Form type
SC 13G/A
Filer
Cellectar Biosciences, Inc.
CIK
CIK 1279704
Filed
Nov 03, 2022
Reporting period
Oct 25, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub